HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

P&G’s Answer To Logistics Challenges In COVID Era: ‘Supply Chain 3.0’

Executive Summary

P&G will provide additional detail at its November Investor Day, but says Supply Chain 3.0 is an adaptation to the new normal that will unlock efficiencies and enable reinvestment in brands.

You may also be interested in...



P&G ‘Clear-Eyed’ On Challenges Ahead; Growth Will Soften, But Strategic Priorities Go Unchanged

Environmental sustainability and DEI will remain key priorities for P&G as it enters a fiscal 2023 that augurs even greater volatility than 2022. The firm’s net sales for the 12 months ended 30 June increased 5%, or 7% organic, to $80.2bn, propelled by an 8% pricing increase in the fourth quarter.

HRA Brings Mederma Scar-Care Brand To UK

British consumers can now buy three Mederma scar-care products in the UK via Amazon and Superdrug thanks to a recent launch by France's HRA Pharma. 

P&G Among US Firms Asked To Explain How, Why Supply Chain Problems Cause Consumer Hardships

Procter & Gamble and Amazon are among nine companies FTC ordered to provide detailed information to help the agency identify causes behind ongoing supply chain disruptions. Chairwoman Khan says the information should “shed light on market conditions and business practices that may have worsened these disruptions.”

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

RS152916

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel